Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9146 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9146 |
High Similarity |
NPD6166 |
Phase 2 |
0.9146 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9018 |
High Similarity |
NPD5494 |
Approved |
0.8827 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8817 |
High Similarity |
NPD7074 |
Phase 3 |
0.8765 |
High Similarity |
NPD1934 |
Approved |
0.8712 |
High Similarity |
NPD2801 |
Approved |
0.8663 |
High Similarity |
NPD7808 |
Phase 3 |
0.8663 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8655 |
High Similarity |
NPD6797 |
Phase 2 |
0.8647 |
High Similarity |
NPD7054 |
Approved |
0.8642 |
High Similarity |
NPD4380 |
Phase 2 |
0.8606 |
High Similarity |
NPD3882 |
Suspended |
0.8605 |
High Similarity |
NPD7251 |
Discontinued |
0.8596 |
High Similarity |
NPD7472 |
Approved |
0.8554 |
High Similarity |
NPD7075 |
Discontinued |
0.8545 |
High Similarity |
NPD3817 |
Phase 2 |
0.8538 |
High Similarity |
NPD5844 |
Phase 1 |
0.8538 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8537 |
High Similarity |
NPD6801 |
Discontinued |
0.8485 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.848 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8439 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8434 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8402 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8383 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8282 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8263 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8214 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8177 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8155 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8144 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.814 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8103 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8075 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8057 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8049 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8012 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8012 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7978 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.795 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7943 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7872 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7872 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7872 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7872 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7872 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7872 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7872 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7869 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD919 |
Approved |
0.7802 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.776 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7749 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7749 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7749 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7749 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7692 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7692 |
Intermediate Similarity |
NPD8312 |
Approved |
0.768 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7663 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7644 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7622 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7617 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7617 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7606 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7606 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7605 |
Intermediate Similarity |
NPD6190 |
Approved |
0.76 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7592 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7579 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7579 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7563 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7563 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7546 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7545 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7531 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7531 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD943 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD920 |
Approved |
0.7475 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7472 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7471 |
Intermediate Similarity |
NPD37 |
Approved |
0.7471 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7471 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7462 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7443 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7443 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7443 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD1653 |
Approved |
0.744 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7435 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7378 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7365 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7347 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7346 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7284 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7267 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD3748 |
Approved |
0.724 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.724 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7202 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD6099 |
Approved |
0.72 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7168 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7166 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7158 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7151 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7104 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7102 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7098 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7098 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7098 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7069 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7066 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7053 |
Intermediate Similarity |
NPD4665 |
Approved |
0.705 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7049 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7049 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7 |
Intermediate Similarity |
NPD5353 |
Approved |
0.6994 |
Remote Similarity |
NPD2309 |
Approved |
0.6988 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6973 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD3823 |
Discontinued |
0.6964 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6959 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6957 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6944 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6935 |
Remote Similarity |
NPD2493 |
Approved |
0.6935 |
Remote Similarity |
NPD2494 |
Approved |
0.6931 |
Remote Similarity |
NPD7583 |
Approved |
0.6928 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6919 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6909 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6905
|
Remote Similarity |
NPD4060 |
Phase 1 |